U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 220380
Company: AMNEAL
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
KETAMINE HYDROCHLORIDE KETAMINE HYDROCHLORIDE EQ 50MG BASE/5ML (EQ 10MG BASE/ML) SOLUTION;INTRAMUSCULAR, INTRAVENOUS Prescription AP No No
KETAMINE HYDROCHLORIDE KETAMINE HYDROCHLORIDE EQ 50MG BASE/ML (EQ 50MG BASE/ML) SOLUTION;INTRAMUSCULAR, INTRAVENOUS Prescription None No Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
11/04/2026 ORIG-1 Approval STANDARD Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/220380Orig1s000ltr.pdf

KETAMINE HYDROCHLORIDE

SOLUTION;INTRAMUSCULAR, INTRAVENOUS; EQ 50MG BASE/5ML (EQ 10MG BASE/ML)
TE Code = AP

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
KETAMINE HYDROCHLORIDE KETAMINE HYDROCHLORIDE EQ 50MG BASE/5ML (EQ 10MG BASE/ML) SOLUTION;INTRAMUSCULAR, INTRAVENOUS Prescription No AP 220380 AMNEAL
KETAMINE HYDROCHLORIDE KETAMINE HYDROCHLORIDE EQ 50MG BASE/5ML (EQ 10MG BASE/ML) SOLUTION;INTRAMUSCULAR, INTRAVENOUS Prescription No AP 219684 BAXTER HLTHCARE CORP
KETAMINE HYDROCHLORIDE KETAMINE HYDROCHLORIDE EQ 50MG BASE/5ML (EQ 10MG BASE/ML) SOLUTION;INTRAMUSCULAR, INTRAVENOUS Prescription No AP 220602 NEURORX
Back to Top